News

FDA approves new at-home rapid COVID-19 test

By Virginia Aabram
Published December 30, 2021 4:19pm ET
Add Washington Examiner on Google
FDA approves new at-home rapid COVID-19 test
The CoviDx test from Lumos Diagnostics gives qualified healthcare providers in Canada qualitative, easy-to-interpret results within 15-20 minutes in cases of suspected COVID-19 and when performing serial testing of asymptomatic patients. Visit lumosdiagnostics.com to learn more. | Business Wire

The Food and Drug Administration has granted emergency use authorization to a new at-home rapid COVID-19 test manufactured by Siemens Healthineers.

The German-American company’s at-home test was approved by the agency Wednesday amid a coronavirus testing shortage as cases surge across the country. Siemens Healthineers said it expects to provide “tens of millions” of tests each month beginning in January.

Already a print subscriber? Click here to login/register your account

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.

Tag:

COVID-19 FDA Pharmaceutical Industry Test